Sinovac Awarded High-Tech Status, Which Brings Lower Taxes And Other Government Benefits
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sinovac Biotech has been granted high-tech enterprise status by three government departments and will get a lower tax rate, at 15 percent, from the standard rate of 25 percent, from 2008 to 2010, the company announced March 9